NovaBay Pharmaceuticals (NBY) Stock Price
$3.73 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
2 -
Technical
8
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on NovaBay Pharmaceuticals, AI stock picks, stock alerts and much more.
NBY AI Stock Analysis
AI stock analysis for NBY is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like NovaBay Pharmaceuticals (NBY) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
NovaBay Pharmaceuticals (NBY) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of NovaBay Pharmaceuticals (NBY), currently trading at $3.73, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NBY
-
NovaBay Pharmaceuticals, Inc.
-
Symbol
NBY
-
Market
AMEX
-
Industry
Biotechnology
-
Market Cap
21.7M
Similar Stocks
 |
Cybin CYBN |
$6.73 12.5% |
4 |
 |
Calidi Biotherapeutics CLDI |
$1.6 1.9% |
5 |
 |
Lineage Cell Therapeutics LCTX |
$1.22 1.7% |
7 |
News
NBY Alternative Data
Web Traffic
NovaBay Pharmaceuticals receives an estimated 2560 monthly visitors to novabay.com.
-
Web Traffic
2560
-
Change from Previous Month
35.7%
-
3 Month Change
73.6%
-
YoY Change
73.6%
Twitter Followers
NovaBay Pharmaceuticals has 4,111 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.
-
Twitter Followers
4111
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Facebook Engagement
NovaBay Pharmaceuticals has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Youtube Subscribers
NovaBay Pharmaceuticals has 129 subscribers on its main Youtube channel.
-
Youtube Subscribers
129
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
6,012 are following NovaBay Pharmaceuticals on LinkedIn, up by 0.4% over the last month.
-
LinkedIn Followers
6012
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.4%
-
YoY Change
0.4%
Job Postings
NovaBay Pharmaceuticals currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, NovaBay Pharmaceuticals has 64 employees, up by 3.2% over the last month.
-
LinkedIn Employees
64
-
Daily Change
0%
-
1 Month Change
3.2%
-
3 Month Change
3.2%
-
YoY Change
3.2%
Business Outlook
According to employee reviews, the business outlook among employees at NovaBay Pharmaceuticals is 35 out of 100 (bearish).
-
Business Outlook
35
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
NovaBay Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
NovaBay Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
NBY Financials
NBY Key Metrics
-
Total Revenue
$2.3M
-
Net Income
-$1.2M
-
Earnings per Share
-$0.34
-
Free cash flow
-$972K
-
EBITDA
-$1.2M
-
EBITDA Ratio
-0.51754
-
Total Assets
$3.4M
NBY 2-year Revenue & Income
NBY 2-year Free Cash Flow
NBY Technicals
NBY SMA
NBY RSI
FAQ
What's the current price of NovaBay Pharmaceuticals (NBY) Stock?
The price of an NovaBay Pharmaceuticals (NBY) share is $3.73.
What's the market cap of NovaBay Pharmaceuticals?
The current market cap of NovaBay Pharmaceuticals is 21.7M.
Should I buy or sell NBY?
NovaBay Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, NovaBay Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is NovaBay Pharmaceuticals a good investment?
The current analysis of NovaBay Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in NovaBay Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy NovaBay Pharmaceuticals (NBY) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for NovaBay Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to NovaBay Pharmaceuticals (NBY) that investors often compare it to?
NovaBay Pharmaceuticals (NBY) is often compared to similar stocks such as Cybin, Calidi Biotherapeutics and Lineage Cell Therapeutics.
What is the forecast for NovaBay Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast NovaBay Pharmaceuticals' stock price to be around $3.62 in 2026. Starting from the current price of $3.73, this represents a 3% change in price, indicating a neutral outlook for the stock.
How to buy NovaBay Pharmaceuticals (NBY) Stock?
NovaBay Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy NovaBay Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.